SCHEMBL22960244

SCHEMBL22960244

O=C1CSc2c1sc1ccc3ccccc3c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRNP P04156 1/20 0.35
TDP1 Q9NUW8 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
PAX8 Q06710 2/20 0.33
NQO1 P15559 1/20 0.33
NQO2 P16083 1/20 0.33
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
ALDH1A1 P00352 3/20 0.32
HSD17B10 Q99714 3/20 0.32
HIF1A Q16665 2/20 0.32
TSHR P16473 2/20 0.32
CYP1B1 Q16678 2/20 0.32
CYP2A6 P11509 1/20 0.32
HPGD P15428 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32
TYMS P04818 2/20 0.31
CYP3A4 P08684 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22960302 0.77 GPR3 (0.41) TDP1L3MBTL1ALDH1A1HPGDKDM4E
SCHEMBL87109 0.70 DNMT1 (0.42) TDP1PAX8CA12CA9ALDH1A1
SCHEMBL30062535 0.70 HSD17B10 (0.52) PRNPTDP1L3MBTL1PAX8NQO1
SCHEMBL13250616 0.70 HSD17B10 (0.52) PRNPTDP1L3MBTL1PAX8NQO1
SCHEMBL13935880 0.68 GPR3 (0.46) PRNPTDP1L3MBTL1NQO1NQO2
SCHEMBL2742604 0.67 MAOA (0.54) TDP1L3MBTL1PAX8NQO1NQO2
SCHEMBL17037122 0.67 HPRT1 (0.50) PRNPTDP1L3MBTL1PAX8NQO1
SCHEMBL2472396 0.67 MAOA (0.46) TDP1PAX8NQO1NQO2CA12
SCHEMBL29436076 0.65 GPR3 (0.54) PRNPTDP1L3MBTL1NQO1NQO2
SCHEMBL29702995 0.65 GPR3 (0.54) PRNPTDP1L3MBTL1NQO1NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11524967-B2 Heteroacene and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-12-13 US disclosed
US-20210040112-A1 HETEROACENE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2021-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11524967-B2 Heteroacene and organic electroluminescence device using the same POF1B, HCN1, HCN2 PRNP 2119/4885TDP1 4151/4885L3MBTL1 1308/4885
US-20210040112-A1 HETEROACENE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME HCN1, HCN2, CACNA1F PRNP 1924/4885TDP1 4107/4885L3MBTL1 1256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.